Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Nov. 30, 2022
Nov. 30, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)    
Revenue $ 101,476 $ 13,880
Cost of Goods Sold 15,795 5,570
Gross profit 85,681 8,310
Expenses    
Research and development 829,489 458,709
Office and administration 1,025,498 1,553,083
Total operating expenses 1,854,987 2,011,792
Net loss (1,769,306) (2,003,482)
Net loss for the period (1,769,306) (2,003,482)
Net loss and comprehensive loss attributable to:    
Common shareholders (1,755,944) (1,993,157)
Non-controlling interest $ (13,362) $ (10,325)
Basic and diluted income (loss) per share $ (0.30) $ (0.35)
Weighted average number of common shares outstanding    
Basic and diluted $ 5,950,998 $ 5,726,699